Top news of May: Obstructive sleep apnea drug combination, central sleep apnea mortality
Click Here to Manage Email Alerts
Healio has compiled the most-read news in pulmonology posted in May.
Highlights include an oral drug combination that lowered obstructive sleep apnea severity; worse mortality outcomes found in veterans with central sleep apnea vs. OSA; ensifentrine found to improve measures of lung function, quality of life and exacerbations in patients with COPD; decreased prevalence of cigarette smoking in 2021; low chances of receiving ECMO treatment in women, Medicaid users and those residing in low-income areas; and more.
Read these and other top stories in pulmonology below:
Oral combination obstructive sleep apnea drug lowers disorder severity over 1 month
A combination of atomoxetine and aroxybutynin taken for 4 weeks lessened obstructive sleep apnea severity, according to an abstract presented at the American Thoracic Society International Conference. Read more.
Central sleep apnea linked to worse mortality outcomes than obstructive sleep apnea
Compared with obstructive sleep apnea, veterans with central sleep apnea had greater mortality rates, shorter time to death and higher mortality hazard, according to study results published in Annals of the American Thoracic Society. Read more.
Ensifentrine improves lung function, exacerbations, quality of life in patients with COPD
Over 12 or 24 weeks, patients with COPD receiving ensifentrine showed improved measures of lung function, quality of life and exacerbation rate, according to an American Thoracic Society International Conference presentation. Read more.
Cigarette smoking in 2021 lowest since 1965
Among the estimated 46 million U.S. adults who used tobacco products in 2021, cigarette smoking prevalence decreased while e-cigarette use increased, according to CDC data published in Morbidity and Mortality Weekly Report. Read more.
Women, Medicaid users less likely to receive ECMO treatment
Low chances for extracorporeal membrane oxygenation treatment were found in women, those with Medicaid insurance and those residing in low-income areas, according to results published in Annals of the American Thoracic Society. Read more.
Helmet CPAP linked to less intubation in patients with COVID-19 respiratory failure
Fewer patients with respiratory failure related to COVID-19 using helmet CPAP experienced intubation compared with facemask CPAP, according to study results published in CHEST. Read more.
Breath data, simple clinical factors identify patients with non-small cell lung cancer
A prediction model that incorporates both exhaled breath data from an electronic nose and basic demographics was able to identify lung cancer in a cohort of patients, according to study results published in CHEST. Read more.
No decreased mortality with high-dose methylprednisolone vs. dexamethasone for COVID-19
Higher dose methylprednisolone and low-dose dexamethasone treatments in patients with COVID-19 pneumonia showed similar 28-day mortality rates, according to study results published in European Respiratory Journal. Read more.
CPAP improves cognition in patients with Parkinson’s disease, obstructive sleep apnea
Among patients with Parkinson’s disease, obstructive sleep apnea and decreased cognition, CPAP therapy improved cognitive function, according to an abstract presented at the American Thoracic Society International Conference. Read more.
Mask wearing showed no negative oxygenation, hemodynamic changes in patients with COPD
Wearing a KF80 mask while exercising and performing daily activities did not impact oxygenation and hemodynamic factors in adults with mild to moderate COPD, according to study results published in Annals of the American Thoracic Society. Read more.